Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative. Sanchez-Cano JG, Munoz-Echeverria L, Casco-Garcia M, Moreno-Nunez L, et al. HIV Med 2026 Apr 20. doi: 10.1111/hiv.70245.

Read + Share

Amedeo Smart

Independent Medical Education

Sanchez-Cano JG, Munoz-Echeverria L, Casco-Garcia M, Moreno-Nunez L, et al. Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative. HIV Med 2026 Apr 20. doi: 10.1111/hiv.70245.
PMID: 42007964